X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
motexafin gadolinium (220) 220
humans (169) 169
index medicus (126) 126
oncology (115) 115
cancer (74) 74
brain neoplasms - secondary (72) 72
radiotherapy (72) 72
radiation-therapy (67) 67
randomized-trial (53) 53
brain metastases (52) 52
brain neoplasms - radiotherapy (50) 50
stereotactic radiosurgery (47) 47
male (42) 42
animals (41) 41
care and treatment (39) 39
female (39) 39
cell lung-cancer (38) 38
neurocognitive function (38) 38
radiation (37) 37
antineoplastic agents - therapeutic use (35) 35
metastases (35) 35
metastasis (35) 35
combined modality therapy (33) 33
radiology, nuclear medicine & medical imaging (33) 33
radiosurgery (33) 33
whole-brain radiation (32) 32
middle aged (31) 31
gadolinium (30) 30
surgery (29) 29
adult (28) 28
apoptosis (28) 28
brain neoplasms - drug therapy (28) 28
brain neoplasms - therapy (28) 28
chemotherapy (28) 28
radiation-sensitizing agents - therapeutic use (28) 28
chemistry, multidisciplinary (27) 27
health aspects (27) 27
texaphyrin (26) 26
aged (25) 25
antineoplastic agents - pharmacology (25) 25
clinical neurology (25) 25
neoplasms - drug therapy (25) 25
pharmacology & pharmacy (25) 25
radiation therapy (25) 25
hematology, oncology and palliative medicine (24) 24
article (23) 23
brain neoplasms - surgery (23) 23
cell line, tumor (23) 23
cranial irradiation (22) 22
photodynamic therapy (22) 22
metalloporphyrins - therapeutic use (21) 21
randomized phase-iii (21) 21
trial (21) 21
clinical trials (20) 20
in-vitro (20) 20
quality-of-life (20) 20
survival (20) 20
therapy (20) 20
cerebral metastases (19) 19
motexafin-gadolinium (19) 19
oxidative stress (19) 19
prognosis (19) 19
therapy-oncology-group (19) 19
treatment outcome (19) 19
medicine & public health (18) 18
research (18) 18
lung neoplasms - pathology (17) 17
magnetic resonance imaging (17) 17
reactive oxygen species - metabolism (17) 17
single metastases (17) 17
tumors (17) 17
analysis (16) 16
biochemistry & molecular biology (16) 16
brain tumors (16) 16
cranial irradiation - methods (16) 16
in-vivo (16) 16
phase-iii (16) 16
prognostic-factors (16) 16
brain metastasis (15) 15
cognition disorders - etiology (15) 15
mice (15) 15
phase-iii trial (15) 15
temozolomide (15) 15
thioredoxin reductase (15) 15
brain (14) 14
brain neoplasms - mortality (13) 13
carcinoma, non-small-cell lung - secondary (13) 13
metalloporphyrins - administration & dosage (13) 13
metalloporphyrins - pharmacokinetics (13) 13
metalloporphyrins - pharmacology (13) 13
phase (13) 13
quality of life (13) 13
radiation sensitizer (13) 13
radiosurgery - methods (13) 13
randomized controlled trials as topic (13) 13
reactive oxygen species (13) 13
aged, 80 and over (12) 12
chemistry, inorganic & nuclear (12) 12
glutathione (12) 12
prophylactic cranial irradiation (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Neuropathology & Experimental Neurology, ISSN 0022-3069, 09/2012, Volume 71, Issue 9, pp. 806 - 813
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 11/2011, Volume 105, Issue 2, pp. 301 - 308
Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 3/2013, Volume 386, Issue 3, pp. 255 - 264
The present study was designed to investigate the potential of gadolinium, a stretch-activated calcium channel blocker in ischemic reperfusion (I/R)-induced... 
Neurosciences | Ischemia–reperfusion injury | Biomedicine | Morris water maze | Calcium | Gadolinium | Pharmacology/Toxicology | Ischemia-reperfusion injury | ISCHEMIA/REPERFUSION INJURY | OXIDATIVE STRESS | RATS | MOTEXAFIN GADOLINIUM | SIGNALING PATHWAY | ENDOTHELIAL-CELLS | BRAIN METASTASES | PHARMACOLOGY & PHARMACY | SPATIAL MEMORY | MICE | CEREBRAL-ISCHEMIA | Gadolinium - administration & dosage | Neuroprotective Agents - therapeutic use | Reperfusion Injury - etiology | Gadolinium - pharmacology | Calcium Channels - metabolism | Calcium - metabolism | Glutathione - metabolism | Calcium Channel Blockers - therapeutic use | Reperfusion Injury - drug therapy | Brain Ischemia - metabolism | Male | Neuroprotective Agents - pharmacology | Neuroprotective Agents - administration & dosage | Reperfusion Injury - metabolism | Disease Models, Animal | Brain Ischemia - complications | Thiobarbituric Acid Reactive Substances - metabolism | Brain Ischemia - physiopathology | Calcium Channel Blockers - pharmacology | Maze Learning - drug effects | Gadolinium - therapeutic use | Rotarod Performance Test | Animals | Brain Ischemia - drug therapy | Calcium Channel Blockers - administration & dosage | Reperfusion Injury - physiopathology | Mice | Muscle Strength - drug effects | Oxidative Stress - drug effects | Acetylcholinesterase - metabolism | Brain | Injuries | Reperfusion injury
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 73, Issue 4, pp. 1069 - 1076
Purpose To determine the efficacy of motexafin gadolinium (MGd) in combination with whole brain radiotherapy (WBRT) for the treatment of brain metastases from... 
Radiology | Hematology, Oncology and Palliative Medicine | Non–small-cell lung cancer | Brain metastases | Whole brain radiotherapy | Neurocognitive function | Motexafin gadolinium | Neurologic progression | Non-small-cell lung cancer | SURVIVAL | RANDOMIZED-TRIAL | RADIATION | METABOLISM | ONCOLOGY | TEXAPHYRIN | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Non-Small-Cell Lung - radiotherapy | Humans | Middle Aged | Proportional Hazards Models | Antineoplastic Agents - therapeutic use | Brain Neoplasms - drug therapy | Lung Neoplasms | Cranial Irradiation - methods | Cognition Disorders - diagnosis | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Metalloporphyrins - therapeutic use | Carcinoma, Non-Small-Cell Lung - secondary | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Brain Neoplasms - therapy | Female | Aged | Combined Modality Therapy - methods | Carcinoma, Non-Small-Cell Lung - drug therapy | Brain Neoplasms - radiotherapy | Metalloporphyrins - adverse effects | Care and treatment | Clinical trials | Gadolinium | Product development | Metastasis | Lung cancer, Non-small cell | Radiotherapy | Index Medicus | SURGERY | GADOLINIUM | PATIENTS | LUNGS | METASTASES | RADIATION DOSES | TOXICITY | LIVER | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | HYPERTENSION | BRAIN
Journal Article
Journal Article
Australian Journal of Chemistry, ISSN 0004-9425, 2015, Volume 68, Issue 4, pp. 576 - 580
The synthesis and characterisation of a new dinuclear Gd-III-Pt-II complex (1 center dot PF6) containing a functionalised macrocyclic... 
CELL LUNG-CANCER | DRUG | TRIAL | THERAPY | CONTRAST AGENTS | FLOW LINEAR DICHROISM | WALLED CARBON NANOTUBES | CHEMISTRY, MULTIDISCIPLINARY | MOTEXAFIN-GADOLINIUM
Journal Article
Chemical Communications, ISSN 1359-7345, 03/2014, Volume 50, Issue 18, pp. 2252 - 2254
The first bifunctional Gd-III complexes covalently bound to arylphosphonium cations and the first tumour-cell selective mitochondrial agents designed for... 
TRIAL | DRUG | LUNG-CANCER | THERAPY | CHEMISTRY, MULTIDISCIPLINARY | MOTEXAFIN-GADOLINIUM | CATIONS
Journal Article